Kathrin Schulz
Impact in
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- RNA modifications and cancer 3
- Mitochondrial Function and Pathology 2
-
- Alzheimer's disease research and treatments 6
- Co-authors
- Anne Eckert (6 shared papers)Wernér E.G. Müller (4 shared papers)Kristina Leuner (4 shared papers)Virginie Rhein (4 shared papers)Marina Jendrach (2 shared papers)Isabel Scherping (1 shared paper)Susanne Hauptmann (1 shared paper)Ulrich Brandt (1 shared paper)
- Journals
- Molecular Neurobiology (3 papers)Carcinogenesis (2 papers)PLoS ONE (2 papers)FEBS Letters (1 paper)Applied Microbiology and Biotechnology (1 paper)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Kathrin Schulz
15 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 85
- Biological Psychiatry 89
- Physiology 612
- Neurology 140
- Aging 19
- Biochemistry 70
Countries citing papers authored by Kathrin Schulz
This map shows the geographic impact of Kathrin Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Schulz more than expected).
Fields of papers citing papers by Kathrin Schulz
This network shows the impact of papers produced by Kathrin Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Schulz. The network helps show where Kathrin Schulz may publish in the future.
Co-authors
The 25 scholars most cited alongside Kathrin Schulz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 391 | |
| 2 | 2010 | 136 | |
| 3 | 2012 | 110 | |
| 4 | 2012 | 108 | |
| 5 | 2007 | 64 | |
| 6 | 2010 | 60 | |
| 7 | 2012 | 48 | |
| 8 | 2012 | 42 | |
| 9 | 2011 | 34 | |
| 10 | 2012 | 26 | |
| 11 | 2018 | 24 | |
| 12 | 2016 | 21 | |
| 13 | 2012 | 18 | |
| 14 | 2017 | 15 | |
| 15 | 2018 | 13 |
About Kathrin Schulz
Kathrin Schulz is a scholar working on Molecular Biology, Physiology, Oncology, Biological Psychiatry and Neurology, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (6 papers), Tryptophan and brain disorders (4 papers), RNA modifications and cancer (3 papers), Peptidase Inhibition and Analysis (3 papers), Neuroinflammation and Neurodegeneration Mechanisms (2 papers), T-cell and B-cell Immunology (2 papers), Mitochondrial Function and Pathology (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Biological Psychiatry (89 citations), Physiology (612 citations), Neurology (140 citations), Aging (19 citations) and Biochemistry (70 citations). Kathrin Schulz has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Anne Eckert, Wernér E.G. Müller, Kristina Leuner, Virginie Rhein, Marina Jendrach, Isabel Scherping, Susanne Hauptmann, Ulrich Brandt, Jürgen Götz and Tobias Schmid. Their work appears in journals such as Molecular Neurobiology, Carcinogenesis, PLoS ONE, FEBS Letters and Applied Microbiology and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.